Colloid scintigraphy in non-alcoholic steatohepatitis: A conventional diagnostic method for an emerging disease
Colloid scintigraphy in non-alcoholic steatohepatitis: A conventional diagnostic method for an emerging disease
复制标题
非酒精性脂肪性肝炎的胶体闪烁扫描:新发疾病的常规诊断方法
DOI:
10.1097/01.mnm.0000203629.15784.2e
复制
发表时间:
2006
影响因子:
1.5
通讯作者:
N. Tözün
中科院分区:
文献类型:
--
作者:
D. Duman;F. Dede;H. Akin;F. Şen;H. Turoğlu;Ç. Çelikel;N. Tözün
AimNon-alcoholic steatohepatitis (NASH) is a progressive liver disease characterized by diffuse fatty infiltration and Kupffer cell dysfunction which contributes to its pathogenesis. Since the liver biopsy, which is considered the ‘gold standard’ in diagnosing NASH, has some limitations other imaging methods have been explored as alternatives. Colloid scintigraphy is a good method reflecting Kupffer cell activity and we found it worthwhile to evaluate this technique in NASH. We aimed to present the common scintigraphic features and their clinicopathologic correlations in NASH. MethodsTwenty-two new patients (11 female, mean age 43.7±10.8) with biopsy-proven NASH underwent colloid liver scintigraphy. The dynamic, static and SPECT images were performed after intravenous injection of 185 MBq 99mTc tin colloid. Hepatic perfusion, blood pool clearance time, colloid shift to spleen and bone marrow were assessed and liver right/left lobe ratio was calculated. ResultsThe values calculated on static and tomographic (SPECT) images showed good correlation. Liver right/left lobe ratio was altered in all patients. Blood pool clearance time was prolonged in seven (32%) but hepatic perfusion was normal in all patients. Colloid shift to the spleen was observed in 55% of patients using SPECT analysis. No correlation between scintigraphy parameters and histological or biochemical findings were observed. ConclusionAltered liver right/left lobe ratio was the universal finding in all our NASH patients. Other common scintigraphic features of NASH include colloid shift to spleen and prolonged blood pool clearance time. Liver scintigraphy might be a promising non-invasive tool in the follow-up of NASH patients in therapeutic trials.